W J Waldman - JoVE Visualize

Showing results (21-30 of 28) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 28 results.

NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987

Comparison of L-thyroxine and a saturated solution of potassium iodide in preventing damage to the thyroid following iodine-131-labeled antibody injectionH Abdel-Nabi, W J Waldman, G H Hinkle, et al.

Pediatric Research|December 1, 1995

Effects of cytomegalovirus infection on growth factor production in endothelial cells and fibroblastsJ S Garrett, J C Narus, J F Bohnsack, et al.

Transplantation|October 9, 1999

Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomideW J Waldman, D A Knight, N S Lurain, et al.

Transplantation|February 1, 1990

Inability of cytomegalovirus infection of cultured endothelial cells to induce HLA class II antigen expressionD D Sedmak, W H Roberts, R E Stephens, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1992

Alloantigenicity of human endothelial cells. 1. Frequency and phenotype of human T helper lymphocytes that can react to allogeneic endothelial cellsP W Adams, H S Lee, W J Waldman, et al.

Intervirology|March 7, 2000

Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomideW J Waldman, D A Knight, L Blinder, et al.

Circulation Research|April 24, 2004

Human cytomegalovirus causes endothelial injury through the ataxia telangiectasia mutant and p53 DNA damage signaling pathwaysY H Shen, B Utama, J Wang, et al.

Bone Marrow Transplantation|October 19, 2004

Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infectionR K Avery, B J Bolwell, B Yen-Lieberman, et al.

Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 28 results.

NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987

Comparison of L-thyroxine and a saturated solution of potassium iodide in preventing damage to the thyroid following iodine-131-labeled antibody injectionH Abdel-Nabi, W J Waldman, G H Hinkle, et al.

Pediatric Research|December 1, 1995

Effects of cytomegalovirus infection on growth factor production in endothelial cells and fibroblastsJ S Garrett, J C Narus, J F Bohnsack, et al.

Transplantation|October 9, 1999

Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomideW J Waldman, D A Knight, N S Lurain, et al.

Transplantation|February 1, 1990

Inability of cytomegalovirus infection of cultured endothelial cells to induce HLA class II antigen expressionD D Sedmak, W H Roberts, R E Stephens, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1992

Alloantigenicity of human endothelial cells. 1. Frequency and phenotype of human T helper lymphocytes that can react to allogeneic endothelial cellsP W Adams, H S Lee, W J Waldman, et al.

Intervirology|March 7, 2000

Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomideW J Waldman, D A Knight, L Blinder, et al.

Circulation Research|April 24, 2004

Human cytomegalovirus causes endothelial injury through the ataxia telangiectasia mutant and p53 DNA damage signaling pathwaysY H Shen, B Utama, J Wang, et al.

Bone Marrow Transplantation|October 19, 2004

Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infectionR K Avery, B J Bolwell, B Yen-Lieberman, et al.

Pageof 3